Aspire Biopharma Holdings, Inc. - ASBP
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 21
Latest filed: Sep 09, 2026
| Form | Count |
|---|---|
| 8-K | 14 |
| SCHEDULE 13G/A | 3 |
| SCHEDULE 13G | 3 |
| 8-K/A | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Sep 09, 2026 | 8-K | Sep 08, 2026 | 0001493152-26-041918 | View |
| Sep 08, 2026 | 8-K | Sep 08, 2026 | 0001493152-26-041725 | View |
| Aug 19, 2026 | 8-K | Aug 19, 2026 | 0001493152-26-039135 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | — | 0000919574-26-005317 | View |
| Aug 10, 2026 | SCHEDULE 13G | — | 0001213900-26-087424 | View |
| Aug 10, 2026 | 8-K | Aug 06, 2026 | 0001493152-26-036777 | View |
| Aug 06, 2026 | SCHEDULE 13G/A | — | 0001493152-26-036445 | View |
| Jul 20, 2026 | 8-K | Jul 20, 2026 | 0001493152-26-033942 | View |
| Jul 02, 2026 | SCHEDULE 13G | — | 0002142929-26-000001 | View |
| Jun 22, 2026 | 8-K | Jun 16, 2026 | 0001493152-26-029599 | View |
| Jun 12, 2026 | 8-K | Jun 09, 2026 | 0001493152-26-028518 | View |
| Jun 12, 2026 | 8-K | Jun 12, 2026 | 0001493152-26-028386 | View |
| May 15, 2026 | SCHEDULE 13G | — | 0000919574-26-003204 | View |
| May 14, 2026 | 8-K | May 11, 2026 | 0001493152-26-023069 | View |
| May 13, 2026 | SCHEDULE 13G/A | — | 0001213900-26-055622 | View |
| Apr 20, 2026 | 8-K | Apr 20, 2026 | 0001493152-26-018018 | View |
| Apr 17, 2026 | 8-K/A | Apr 15, 2026 | 0001493152-26-017145 | View |
| Apr 16, 2026 | 8-K | Apr 10, 2026 | 0001493152-26-017054 | View |
| Apr 16, 2026 | 8-K | Apr 15, 2026 | 0001493152-26-017115 | View |
| Apr 16, 2026 | 8-K | Apr 16, 2026 | 0001493152-26-016979 | View |
| Apr 15, 2026 | 8-K | Apr 15, 2026 | 0001493152-26-016683 | View |